liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Management of infections caused by respiratory syncytial virus
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Show others and affiliations
2001 (English)In: Scandinavian Journal of Infectious Diseases, ISSN 0036-5548, E-ISSN 1651-1980, Vol. 33, no 5, 323-328 p.Article in journal (Refereed) Published
Abstract [en]

This is a consensus document compiled by the Medical Products Agency in Sweden and the Swedish Reference Group for Antiviral Therapy on management of respiratory syncytial virus (RSV) infections. Prophylaxis against RSV infections using palivizumab, a commercially available humanized monoclonal IgG, antibody preparation, is recommended for children <2 y of age with chronic respiratory diseases requiring continuous treatment (oxygen and/or inhalations and/or steroids) during the previous 6 months and children 6 months old who were born before gestational week 26. Ribavirin inhalation treatment may be considered in high-risk infants with clinical symptoms indicating a serious course of an RSV infection. Treatment with ribavirin in combination with intravenous polyclonal immunoglobulin should be considered in patients who have received an allogenic stem cell transplantation or organ transplantation with >1 episode of rejection treatment and who have mild or moderate RSV pneumonia. Evidence-based documentation for treatment of other groups of patients is lacking.

Place, publisher, year, edition, pages
2001. Vol. 33, no 5, 323-328 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-49212OAI: oai:DiVA.org:liu-49212DiVA: diva2:270108
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2017-12-12

Open Access in DiVA

No full text

Authority records BETA

Lindroth, Margaretha

Search in DiVA

By author/editor
Lindroth, Margaretha
By organisation
Faculty of Health SciencesMedical Microbiology
In the same journal
Scandinavian Journal of Infectious Diseases
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 58 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf